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Abstract 
The N-Methyl-D-Aspartate receptor (NMDAR) is fundamental to normal and pathological 
functioning of neurons. The receptor subunits are N-glycosylated proteins synthesized in the endoplasmic 
reticulum (ER) which fold, mature and oligomerize as they transit through the secretory pathway. Although 
the early processes of biogenesis are fundamental to NMDAR expression and function, our knowledge of 
them is nevertheless limited. Additionally, the investigation of NMDAR synthesis is highly relevant because 
ER dysfunction, frequently associated to acute and degenerative brain diseases, might alter this process.   
We characterize here the effect of ER stress produced by inhibition of N-glycosylation on NMDAR 
synthesis and function. We use first heterologous systems of NMDAR expression where NR1 and NR2A 
subunits are synthesized in non-neuronal cells. The function of these NMDARs as Ca2+ channels is repressed 
by tunicamycin, due to the inhibition of NR1, but no NR2A, synthesis. The regulation of NR1 is relevant to 
central nervous system since a dramatic decrease in synthesis of this subunit and assembly of NMDARs is 
observed in cortical neurons treated with tunicamycin. The inhibition of NR1 synthesis is not due to changes 
in levels of mRNA but associated to the earliest stages in NMDAR biogenesis. The inhibition of N-
glycosylation activates ER specific stress responses in neurons, which include the ER-associated degradation 
(ERAD), mechanism responsible for differential and extremely efficient degradation of nonglycosylated 
NR1 by the proteasome after ubiquitination. Since this is an obligatory NMDAR component, the significant 
sensitivity of NR1 to ER stress will have important consequences on receptor function. 
 
Keywords: NMDA receptors; ER stress; ERAD; N-glycosylation; quality control; tunicamycin 
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Introduction 
The N-Methyl-D-Aspartate type of glutamate receptor (NMDAR) plays crucial roles in neuronal 
plasticity, learning and memory, fundamentally due to its high Ca2+ permeability (Mori and Mishina 1995). 
Physiological levels of synaptic NMDAR activity are also extremely important for neuronal survival 
(Hardingham et al. 2002; Papadia et al. 2005), while agonist overstimulation can induce excitotoxic cell 
death and contribute to neuronal degeneration in different disorders (Choi 1988). Thus, the regulation of 
NMDAR expression and function is fundamental to maintain or adjust neuronal excitability to changing 
demands, avoiding neuronal dysfunction and death. 
The NMDARs are hetero-oligomeric proteins formed by obligatory NR1 subunits interacting with 
NR2A-D, conferring functional variability (Cull-Candy and Leszkiewicz 2004). The subunits are N-
glycosylated proteins synthesized in the endoplasmic reticulum (ER). The earliest events in NMDAR 
biogenesis, including N-glycosylation, folding, carbohydrate maturation, oligomerization and transport to 
the plasma membrane take place along the secretory pathway. Although critical to NMDAR expression and 
function, our knowledge of them is nonetheless limited. A well-established feature is the different trafficking 
of NR1 and NR2 subunits. Approximately 50-60% of NR1 does not reach the cell surface (Hall and 
Soderling 1997) and constitutes an intracellular pool of immature protein of very short half-life compared to 
NR2A-assembled NR1 reaching the cell surface (Chazot and Stephenson 1997; Garcia-Gallo et al. 1999; 
Huh and Wenthold 1999).  
Interestingly, ER dysfunction is observed in cerebral ischemia and other acute and neurodegenerative 
diseases (Paschen and Mengesdorf 2005). In addition, congenital disorders of glycosylation (CDGs), a group 
of inherited disorders caused by defects in synthesis and processing of N-glycans, are associated to impaired 
central nervous function in nearly all cases (Jaeken 2003; Freeze 2006). A possibility is that the earliest 
events in the biogenesis of key proteins in the central nervous system, such as the NMDAR, might be 
modified by ER malfunction and contribute to neuronal damage.  
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Given its central role in protein synthesis and calcium homeostasis, different signaling pathways have 
evolved to preserve ER function in a stress situation, for example due to accumulation of misfolded proteins. 
These pathways are collectively known as the “unfolded protein response” (UPR) (Kaufman 1999) or ER 
stress response.  They consist in the inhibition of protein synthesis (Harding et al. 2000), reducing the work-
load imposed on the folding machinery, and transcriptional induction of genes encoding ER chaperones and 
proteins involved in different steps in the secretory pathway (Casagrande et al. 2000; Gething and Sambrook 
1992; Kozutsumi et al. 1988; Travers et al. 2000). The ER also prevents misfolded or misassembled proteins 
from moving along the secretory pathway by another response known as the quality control system. 
Defective proteins are retained in the ER and, eventually, degraded by a mechanism known as ER-associated 
degradation (ERAD) (Bonifacino and Weissman 1998) that requires retrotranslocation to the cytosol and 
proteasomal degradation following ubiquitination (Brodsky and McCracken 1999). Finally, in the case of 
persistent or intense stress, the ER can also trigger apoptosis (Boyce and Yuan 2006). 
In this investigation we characterize the susceptibility of the NMDAR to ER stress induced by 
inhibition of N-glycosylation. To this aim, we analyze the effect of the suppression of N-glycosylation by 
tunicamycin on recombinant NMDARs or those produced by cortical neurons. We show that treatment with 
this antibiotic inhibits NMDAR function. In the context of the ER stress response induced in neurons by 
tunicamycin, we identify NR1 as a NMDAR subunit differentially sensitive to ER stress, and show it to be a 
substrate of the ERAD mechanism. Since NR1 is an essential receptor component, degradation of newly 
synthesized protein will have a great impact on NMDAR expression and function. 
 
Materials and Methods 
Chemicals - NMDA receptor antagonist 2-amino-phosphono-pentanoic acid (DL-AP5) and MK-801 
were from Tocris-Cookson (Bristol, UK). Tunicamycin, N-acetyl-leucyl-leucyl-norleucinal (calpain 
inhibitor I, herein ALLN), N-acetyl-leucyl-leucyl-methional (calpain inhibitor II, herein ALLM), brefeldin 
A, cytosine -D-arabinofuranoside (AraC), poly-L-lysine, and L-laminin were all from Sigma Co (St. Louis, 
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MO). N-glycosydase F was from Roche Molecular Biochemical (Mannheim, Germany). MG132 and clasto-
lactacystin-ß-lactone were purchased from Calbiochem Novabiochem. 45CaCl2 (36 mCi/mg) was obtained 
from DuPont NEN. All other products were of the highest quality available.  
Cell culture – Human embryonary kidney cells HEK293 (ATCC CRL 1573) were grown in 
Dulbecco’s modified Eagle medium (DMEM) plus 10% fetal bovine serum, 40 µg/ml gentamicin and 2 mM 
glutamine. African green monkey kidney cells (BSC-40) were grown as before but using newborn calf 
serum. Cells were grown at 37°C in 5% CO2. Vaccinia virus was manipulated in the P2 facility of the 
Instituto de Investigaciones Biomédicas. For immunofluorescence experiments, HEK293 were grown on 
coverslips previously treated with 0.2% gelatin for 2 h at 37oC, and then washed and dried under sterile 
conditions. Primary culture of embryonic rat neurons was performed basically as described (Rose et al. 
1993) with some modifications. Plates were treated with poly-L-lysine (100 µg/ml) and laminin (4 µg/ml) 
overnight at 37°C before seeding. Cerebral cortices from 18-days old rat embryos (Wistar) were dissected 
and mechanically dissociated in culture medium (Eagle minimum medium supplemented with 28.5 mM 
NaHCO3, 22.2 mM glucose, 0.1 mM glutamine, 5% FBS and 5% donor horse serum). Cells were seeded at a 
density of 0.3x106 cells/cm2 in the same media. To inhibit growth of glial cells, AraC (10 µM) was added to 
the culture at day 12 and kept for the next 48 h. 
Plasmids and viruses - Plasmids coding for NR1-1a splice variant (Moriyoshi et al. 1991) and NR2A 
(Ishii et al. 1993) subunits of the rat NMDAR were kindly supplied by Dr. S. Nakanishi. The plasmid 
containing a dog calnexin cDNA was provided by Dr. D. Williams (University of Toronto, Ontario, 
Canada). All these cDNAs were cloned in pBlueScript (Stratagene, La Jolla, CA). Dr. A. S. Lee (University 
of Southern California, Los Angeles, USA) gave us plasmids pTZSSB-BiP and pTZ-CHOP containing 
hamster cDNAs, respectively coding for chaperone grp78/BiP and transcriptional factor CHOP/GADD153. 
Plasmid YFP-NR1, generously provided by Dr. J. Luo (Zhejiang University School of Medicine, China), 
encodes the NR1-1a subunit containing the yellow florescence protein (YFP) inserted between the third and 
fourth codons after the predicted sequence for the signal peptide (Qiu et al. 2005). Plasmid pME18S-HA-
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NR2A was a generous gifts of Dr. T. Yamamoto (University of Tokyo, Japan) and contain the rat NR2A 
cDNA with a hemagglutinin epitope in the N-terminus between amino acid residues 51 and 52 (Hironaka et 
al. 2000). The recombinant VV vTF7-3 expressing the T7 RNA polymerase gene under the control of the 
virus early/late promoter p7.5 (Fuerst et al. 1987) was grown and titrated in BSC-40 cells according to 
standard procedures. 
Heterologous expression of recombinant NMDAR - HEK293 cells (3 x 106, in 6-well plates) were 
infected with vTF7-3 virus at a multiplicity of 4 plaque forming units (pfu) per cell for 1 hr at 37°C. After 
adsorption, virus inoculum was removed, cells were washed once with DMEM with no serum and 
transfected using Transfectace liposomes as described (Garcia-Gallo et al. 1999). Transfection of NR1 and 
NR2A cDNAs was performed with 4 µg each plasmid. Control transfections were done replacing these 
plasmids by pBlueScript SK (-) as required. Lipids and DNA were incubated for 15 min in DMEM without 
serum and then added to the infected cells for 5-6 h. Then, cells were fed with DMEM containing 10% 
serum, 2 mM DL-AP5, a competitive antagonist used to prevent NMDAR activation by glutamate present in 
the culture media, and 2 µg/ml tunicamycin, as indicated. Incubation proceeded up to 24 h after infection 
before further treatment. Alternatively, HEK293 cells (2 x 105, in 24-well plates) grown on coverslips were 
transfected with 0.5 µg of plasmids YFP-NR1 and pME18S-HA-NR2A using standard calcium phosphate 
methods. After 5 h of transfection, cells were washed and fed with DMEM plus 10% fetal bovine serum, 2 
mM DL-AP5 and 2 µg/ml tunicamycin, as indicated. Incubation proceeded for another 24 h before fixation. 
Calcium influx through the NMDA receptor - Cells (0.8x106) were infected/transfected as before with 
or without tunicamycin. Twenty-four hours after infection, they were washed three times with 120mM NaCl, 
5.4mM KCl, 0.8 mM MgCl2, 15mM glucose, 20mM Hepes (pH 7.4), 10mM NaOH, 0.002% Phenol Red 
(HCSS medium) (Rose et al. 1993), containing 1.8 mM CaCl2 and 10 µM glycine. Then, cells were 
incubated for 5 min at room temperature in 250 µl of the same medium with the addition of 1mM NMDA 
and 1.25 µM 45CaCl2 (the final concentration in the assay was 5 µCi/ml), with or without 10 µM MK-801 as 
indicated (Lu et al. 1996). Cells were then washed four times in HCSS/calcium/glycine medium as before, 
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and lysed with 0.4 ml of 2% SDS with occasional swirling for 20 min at room temperature before counting 
radioactivity. 
Metabolic labeling - Cells were starved in DMEM medium without methionine nor cysteine  
(Biowhittaker) for 3 h in the presence of 2 mM (HEK293 cells) or 200 µM DL-AP5 (neurons). Then, they 
were pulsed for 30 min (HEK293 cells) or labeled for 4 h (neurons) using 150 µCi/ml of 35S-Methionine. 
The time of labeling for neurons was established as the minimum required for an efficient detection of the 
subunits. After that, cells were washed in cold PBS before lysis in 1% NP-40, 20 mM Tris-Cl (pH 8), 80 
mM NaCl, and 20 mM EDTA (HEK293 cells) or RIPA buffer (10 mM Na2HPO4, pH 7.2, 150 mM NaCl, 
1% sodium deoxicolate, 1% NP-40, 0.1% SDS) (neurons) for 30 min at 4°C. Lysis buffers contained 
protease inhibitors at the following concentrations: 1 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml aprotinin 
and 10 mM benzamidine. When indicated tunicamycin (2 µg/ml), brefeldin A (5 µg/ml), MG132 (20 µM), 
ALLN (50 µM), ALLM (50 µM) and lactacystin (50 µM) were added during starvation and maintained 
during the time of labeling.  
Immunoprecipitation - HEK293 and neuron protein extracts were diluted respectively with one or two 
volumes of their corresponding lysis buffers but lacking detergents. Approximately 200 µg of protein were 
incubated with 2.5 µg of a mouse monoclonal antibody specific for the NR1 subunit (aminoacids 660 to 
811) (Pharmingen, San Diego, CA), or 0.5 µg of rabbit polyclonal antibodies specific for the C-terminus of 
NR2A and 2B subunits or calnexin (Chemicon, Temacula, CA). After 1h at 4°C, immunocomplexes were 
precipitated with 100 µl of 10% Protein A Sepharose also for 1 h at the same temperature. Beads were 
washed four times with the buffer used for immunoprecipitation before solubilization in sample buffer and 
gel fractionation. Detection of the immunoprecipitated proteins was performed by autoradiography of dried 
gels or immunoblotting, with the same  antibody used for immunoprecipitation or  a different one. 
Immunoblot analysis – Cortical cultures were lysed in RIPA buffer containing protease inhibitors as 
before. Protein determination was performed using the BCA reagent from Pierce (Rockford, IL).  Equal 
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amounts of total extracts (25-50 µg) or proteins immunoprecipitated as described were fractioned by 
polyacrylamide gel electrophoresis and transferred to PVDF membranes (Pall, Life Sciences). 
Immunodetection of proteins was performed by standard procedures using the antibodies mentioned above 
as well as mouse monoclonal antibodies for the pro-apoptotic transcriptional factor CHOP/GADD153 (Santa 
Cruz Biotechnology, Santa Cruz, CA), a rat monoclonal antibody specific for caspase-12 generously 
provided by Dr. J. Yuan (Harvard Medical School, USA) (Nakagawa et al. 2000) or rabbit polyclonal 
antibodies that recognize calnexin (Chemicon, Temacula, CA) or ubiquitin (DakoCytomation, Denmark). 
Goat secondary antibodies coupled to horseradish peroxidase were from Santa Cruz Biotechnology (Santa 
Cruz, CA). Immunocomplexes were detected with the Bioluminescence kit from Perkin-Elmer Life Sciences 
(Boston, MA). 
Immunofluorescence – Transfected HEK293 were fixed in 4% (w/v) paraformaldehyde in PBS for 2 
min at 40C and washed with PBS. Then, cells were permeabilized and blocked for 30 min at room 
temperature in 10% (v/v) horse serum, 0.1% (v/v) Triton X-100 in PBS. Dilution of the antibodies was 
performed in 10% (v/v) horse serum and cells were incubated for 1 h at room temperature as indicated. We 
used a rabit antibody for GFP (Invitrogen, Carlsbad, CA) and a goat polyclonal sera for NR2A (Santa Cruz 
Biotechnology, Santa Cruz, CA). Immunoreactivity was detected with secondary antibodies conjugated to 
Alexa Fluor 488 or Alexa Fluor 594 (Molecular Probes, Eugene, OR) as indicated, before mounting with 
Fluoromount-G (SouthernBiotech). Confocal images were acquired using a Radiance 2000 confocal 
(BioRad) coupled to an inverted Axiovert S100 TV microcope (Zeiss) with a 63x Plan-Apochromat oil 
immersion objective. Overlaying images produced the two-color merged image.  
Northern blot analysis - Total RNA was prepared using “TriReagent” (Sigma Co., St. Louis, MO) 
according to the manufacturer's instructions. Approximately 10 µg of total RNA were fractionated on 1% 
agarose gels prepared in 20 mM MOPS buffer, pH 7.2, 0.6% formaldehyde. After transfer to Nylon 
membranes, the RNA was hybridized to DNA probes corresponding to nucleotides 344 to 1280 of the NR1-
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1a splice variant, or cDNAs encoding calnexin, BiP/grp78 and CHOP/GADD153 as described, labeled by 
standard procedures. 
Results 
Calcium influx mediated by recombinant NMDARs is suppressed by inhibition of N-glycosylation - 
We expressed recombinant NMDARs very efficiently in non-neuronal cells using a vaccinia virus-regulated 
system and transfection of the cDNAs encoding subunits NR1 and NR2A (Garcia-Gallo et al. 1999). The 
NMDARs induced a significant net accumulation of 45Ca2+ in HEK293 cells treated with the receptor co-
agonists NMDA and glycine (0.83 nmoles/5 min), which was significantly reduced in the presence of the 
NMDAR antagonist MK-801 (0.12 nmoles/5 min; p<0.01) (Fig. 1). Only receptors formed by NR1 and 
NR2A subunits were capable to induce 45Ca2+ accumulation upon activation, while homomeric NR1 
receptors could not. Once demonstrated that heteromeric NMDARs expressed in this way are functional and 
respond to specific receptor agonists and antagonists, we  analyzed the effect of the inhibition of N-
glycosylation on NMDAR function. The net accumulation of 45Ca2+ was significantly reduced by 2 µg/ml of 
tunicamycin (0.21 nmoles/5 min) compared to untreated cells (p<0.01). These low levels of 45Ca2+ influx 
were close to those obtained in the presence of MK-801, or in cells expressing the NR1 subunit alone. In 
conclusion, the results presented in this experiment demonstrate that N-glycosylation of the receptor 
subunits is required for NMDAR function. 
Synthesis of recombinant NR1 subunits is differentially blocked by inhibition of N-glycosylation – The 
inhibition of N-glycosylation frequently affects stability and trafficking of proteins in the secretory pathway, 
although this is not a universal fact. To characterize the mechanism responsible for the lack of NMDAR 
function in the presence of tunicamycin, we first analyzed de novo synthesis of the receptor subunits by a 30 
min pulse with 35S-methionine (Fig. 2A). Before pulse, cells were pretreated for 3 h with tunicamycin, a 
time established as the minimum required for complete blockage of N-glycosylation without general 
inhibition of protein synthesis as part of the UPR (Harding et al. 2000). Synthesis of the subunits was then 
analyzed by immunoprecipitation with specific antibodies (herein IPNR1 and IPNR2) followed by 
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autoradiography of the 35S-labeled proteins. In tunicamycin-treated cells, nonglycosylated (ng) NR2A (Mr
165-kDa) was the sole de novo synthesized NR2A while the untreated cells produced similar levels of the 
glycosylated form of this subunit (Mr 180-kDa) (Fig. 2A, lower panel). Shorter times of tunicamycin 
pretreatment resulted in mixed populations of NR2A and ngNR2A subunits (data not shown). Contrary to 
that, we detected the glycosylated form of NR1 (Mr 116-kDa) in the untreated cells (Fig. 2A, upper panel) 
but no protein corresponding to ngNR1 (Mr 97-kDa) after tumicamycin treatment. Immunoblot analysis (IB) 
of the immunoprecipitated proteins (Fig. 2B) showed that this short treatment with tunicamycin however had 
no effect on the steady-state levels of the subunits, and that the total amount of ngNR2A was still too low to 
be detected in this way. The monoclonal NR1 antibody recognizes a sequence present in the different NR1 
isoforms and, then, they are all regulated by tunicamycin. Since that sequence includes two of the NR1 
consensus N-glycosylation sites, there was a possibility that the antibody could not immunoprecipitate 
ngNR1 subunits. Therefore, total extracts were deglycosylated in vitro with N-glycosydase F before 
immunoprecipitation and immunoblot analysis with the NR1 antibody (Fig. 2C), finding that deglycosylated 
and glycosylated NR1 were similarly recognized. All together, these results strongly suggest that the 
selective blockage in the synthesis of the NR1 isoforms, obligatory subunits of the NMDAR, causes the loss 
of the receptor function.   
Interestingly, de novo synthesis of NR2A, also an N-glycosylated protein, is not affected by the 
inhibition of N-glycosylation. However, transport of newly synthesized NR2 subunits to the cell membrane 
has been shown to require synthesis of NR1 (Fukaya et al. 2003). Therefore, we further investigated the 
destiny of ngNR2A by immunofluorescence of permeabilized HEK293 cells after standard transfection of 
cDNAs encoding tagged-subunits (Fig. 2D). In the untreated cells, we observed a very good co-localization 
of the NR1 and NR2A proteins in the plasmatic membrane while ngNR1 became hardly detectable in 
tunicamycin-treated cultures. On the contrary, we detected high levels of ngNR2A but this protein was not 
transported to the membrane and formed intracellular aggregates. These results, obtained using an 
alternative heterologous system, not only allowed confirmation of previous observations but also discarded 
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the possibility that NR1 regulation induced by inhibition of N-glycosylation was helped by subunit over-
expression in the virus-regulated system.  
Blockade on NR1 but no NR2 synthesis is induced in cortical neurons by inhibition of N-glycosylation 
– The results obtained in the heterologous systems suggested that the earliest events in the synthesis of the 
NMDAR might be affected by inhibition of N-glycosylation in the central nervous system. To investigate 
this possibility, we analyzed primary cultures of rat embryonic cortical neurons of 14 days in vitro (DIVs 
14), when de novo synthesis of NMDAR subunits is very active (data not shown). The main NR2 subunits 
expressed in cortical neurons at this time in culture are NR2A and NR2B (herein NR2), which have similar 
molecular weight and cannot be distinguished by antibodies directed to their conserved regions. We first 
performed metabolic-labeling with 35S-methionine in the presence or absence of tunicamycin (4 h), and 
analyzed synthesis of the NMDAR subunits by immunoprecipitation with specific antibodies and 
autoradiography (Fig. 3A). Quantitation of the results obtained in three independent experiments (Fig. 3B) 
demonstrated that levels of 35S-labeled ngNR1 were reduced by 77% in the treated neurons compared to N-
glycosylated subunits expressed in the untreated cultures (p<0.001). Contrary to that, levels of ngNR2A and 
ngNR2B (ngNR2) in cells treated with tunicamycin were only modestly reduced (28%) compared to those of 
the untreated cells, probably due to general inhibition of protein synthesis as will be shown below. However, 
the difference in the relative levels of 35S-labeled ngNR1 and ngNR2 was significant (p<0.001). Immunoblot 
analysis of the immunoprecipitated proteins showed that this short treatment with tunicamycin (7 h) had no 
effect on the steady-state levels of NR2 (Fig. 3C) or NR1 (Fig. 3D), and only a small amount of ngNR2 
could be detected in the treated neurons although the glycosylated form was still the most abundant (Fig. 
3C). Longer treatments with tunicamycin (W 24 h) were needed to observe modest decreases in the steady-
state levels of NR1 subunit (data not shown). From these experiments, we conclude that there is  a specific 
blockage of NR1 synthesis induced by inhibition of N-glycosylation, which does not occur for the other 
subunits forming the NMDAR in cortical neurons. 
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Disruption of NMDAR assembly in cortical neurons induced by inhibition of N-glycosylation – The 
interference with N-linked glycosylation may disrupt other processes occurring in the secretory pathway 
and, therefore, we next analyzed if that is true for the NMDAR. Cortical cultures were labeled as before in 
the presence or absence of tunicamycin and/or brefeldin A, a drug causing the collapse of Golgi stalks on the 
ER, thus inhibiting processes in the secretory pathway taking place beyond the ER (Klausner et al. 1992). 
We performed immunoprecipitations in conditions compatible with co-immunoprecipitation of interacting 
proteins (Fig. 4). The immunoprecipitation of NR1 not only showed the expected decrease in levels of newly 
synthesized ngNR1 in tunicamycin-treated cells, but also in neurons treated with brefeldin A together with 
tumicamycin (Fig. 4A). Therefore, the inhibition of NR1 synthesis is a process previous to export from the 
ER to the Golgi compartment. The pattern of NR1 observed in the control cells, characteristic of N-
glycosylated proteins, was simplified in neurons treated with brefeldin A (Fig. 4A) suggesting that the 
lower-mobility protein probably corresponds to a form of NR1 that needs exit of the ER for carbohydrate 
maturation. Anyway, NR2 was co-immunoprecipitated with both maturation forms of NR1 demonstrating 
that interaction between the NMDAR subunits is already established in the ER. However, assembly of the 
NMDAR required N-glycosylation, as shown by the absence of interaction between ngNR2 and ngNR1 
(Figs. 4A and 4B). As before, synthesis of NR2 was not modified by tunicamycin (Fig. 4B), and only a 
small fraction of newly synthesized NR1 interacts with NR2 in the untreated cells (compare Figs. 4A and 
4B), as previously described (Huh and Wenthold 1999). In conclusion, these results demonstrate the 
existence of a mechanism induced by the inhibition of N-glycosylation causing a significant decrease in the 
synthesis of NR1 subunits and also in the assembly of heteromeric NMDARs in the ER compartment. 
Inhibition of NR1 synthesis induced by tunicamycin is not due to changes in mRNA levels - To further 
characterize the mechanism responsible for the inhibition of NR1 synthesis, we next compared by Northern 
blot analysis the levels of NR1 mRNA in neurons treated or not with tunicamycin for a time known to block 
de novo synthesis of this protein (7 h) (Fig. 5A). We found no significant variation in the NR1 mRNA levels 
normalized to rRNA, used as a control. Quantitation of three independent experiments showed a 97% +/- 8.3 
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of the NR1 mRNA levels remaining after 7 h of treatment, compared to the untreated neurons. Longer 
treatments with tunicamycin (24 h) were required to observe reductions in the amounts of NR1 mRNA (Fig. 
5A), although they were no specific. Similar decreases were also produced for calnexin mRNA or 28S and 
18S rRNAs, and they are probably due to apoptosis associated to prolonged ER dysfunction. In conclusion 
we show that, before a general degradation of RNA takes place, there is a specific mechanism on NR1 
synthesis induced by inhibition of N-glycosylation, which cannot be explained by a decrease in the levels of 
its encoding mRNA.  
Induction of an ER stress response in cortical neurons by inhibition of N-glycosylation – The results 
presented so far suggested that inhibition of NR1 synthesis might be associated to ER stress responses 
induced by tunicamycin in cortical neurons. To investigate the activation of these signaling cascades, we 
first analyzed the transcriptional induction of genes important for the UPR (Fig. 5A). In neurons treated for 7 
h with tunicamycin, we demonstrated the induction of the mRNA for the ER chaperone grp78/BiP which 
resulted in a corresponding increase in protein levels (data not shown). Similarly, the mRNA encoding for 
the pro-apoptotic transcriptional factor CHOP/GADD153 was induced (Fig. 5A), contributing to a 
significant increase in levels of this protein in neurons treated with tunicamycin (Fig. 5B, upper panel). 
These inductions were specific for stress-related genes and not observed for other mRNAs or proteins such 
as calnexin (respectively, Fig. 5A and Fig. 5B, lower panel). The UPR also results in a general inhibition of 
protein translation and, therefore, we measured the 35S-methionine incorporation as trichloro-acetic acid 
precipitable protein. We found a 25.3% inhibition of de novo synthesis in neurons treated with tunicamycin 
for 7 h compared to the untreated cells.  
Finally, persistent or intense ER stress can also trigger apoptosis, a process where activation of pro-
caspase-12 has a leading role (Nakagawa et al. 2000). Our results showing rRNA degradation (Fig. 5A) or 
induction of CHOP/GADD153 (Fig. 5B, upper panel) strongly suggested apoptosis induction in cortical 
neurons after prolonged inhibition of the N-glycosylation. We confirmed this point by characterizing the 
activation of pro-caspase-12 (Fig. 5B, middle panel), observing a processing indicative of enzyme activation 
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after 7 h of tunicamycin treatment, although activation dramatically increased afterwards. In conclusion, all 
together these results demonstrate that blockage of N-glycosylation in primary cultures of cortical neurons 
activates ER specific signaling pathways directed to promote cell survival or, after persistent inhibition, 
apoptosis.  
Nonglycosylated NR1 subunits are differentially degraded by the proteasome in cortical neurons –
Among the adaptative pathways constituting the ER stress response, the activation of proteasome-dependent 
ERAD is fundamental to remove misfolded or unassembled proteins from the ER, and alleviate the burden 
on this organelle. Thus, we investigated if ngNR1 might be a specific substrate of the ER quality control 
system in neurons treated with tunicamycin. In that case, ngNR1 would be retrotranslocated to the 
cytoplasm, ubiquitinated and degraded by the proteasome soon after synthesis. We analyzed as before de
novo synthesis of NR1 in neurons treated with tunicamycin and different inhibitors of the proteasome (Fig. 
6). We first used MG132, a reversible inhibitor of the proteasome, and observed that the levels of ngNR1 
significantly increased in neurons treated with tunicamycin together with MG132 compared to cells only 
incubated with the antibiotic (Fig. 6A, upper panel). Quantitation of the results (Fig. 6B) showed that 
synthesis of NR1 was only reduced a 40% in those neurons, compared to a 77% inhibition found in cultures 
treated with tunicamycin alone, being these differences significant (p<0.001). As shown before for NR2, 
inhibition of N-glycosylation only had minor effects on the synthesis of calnexin, which were independent 
of the presence of MG132 (Fig. 6A, lower panel). Next, we established that the ngNR1 subunit 
immunoprecipitated in neurons treated with tunicamycin and MG132 was ubiquitinated, since an antibody 
specific for ubiquitine recognized it in immunoblot (Fig. 6C).  
Given that MG132 has been reported to be also active on neutral cystein proteases such as calpain 
(Tawa et al. 1997), we decided to analyze other proteasome inhibitors. We used ALLN, a proteasomal 
inhibitor when employed at high concentrations (50 XM) or, as a negative control, ALLM, a related peptide 
of 50-100-fold lower potency (Fig. 6D). Combined treatment with tunicamycin and ALLN notably increased 
the amount of 35S-labeled ngNR1 compared to cells treated with tunicamycin and ALLM, or with antibiotic 
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alone (Fig. 6D, upper panel). Finally, by using the specific proteasome irreversible inhibitor lactacystin (Fig. 
6D), we also observed a significant increase in levels of ngNR1 in cells incubated with tunicamycin and 
lactacystin compared to cultures treated with the antibiotic alone. As seen before, levels of the NR2 subunits 
were nearly equivalent in the different conditions tested (Fig. 6D, lower panel). Therefore, these results 
demonstrate that the activity of the proteasome is required for the decrease in levels of ngNR1 induced by 
inhibition of N-glycosylation and that ER-associated NR1 degradation is the mechanism responsible for it. 
 
Discussion 
Considering the central role of the NMDAR in the physiopathology of the central nervous system, and 
given that the receptor subunits are synthesized, modified and assembled in the ER, it was essential to 
investigate the effect of altered ER function on NMDAR expression and functioning. In this investigation, 
we have analyzed the consequences of ER dysfunction induced by the inhibition of N-glycosylation on 
recombinant NMDARs produced in heterologous expression systems and in the receptors expressed in 
primary cultures of rat cortical neurons. The function of the NMDAR as Ca2+ channel is significantly 
inhibited by tunicamycin in a vaccinia virus-regulated heterologous system, explaining our previous 
observations showing a dramatic decrease in cell death due to NMDAR overactivation after treatment with 
this antibiotic (Garcia-Gallo et al. 1999). The suppression of N-glycosylation frequently affects the function 
of proteins by modifying their stability and trafficking in the secretory pathway. However, the role of this 
modification must be examined for each protein since is not universal and may be different even for related 
proteins (Diop and Hrycyna 2005). In the case of the NMDAR, the mechanism responsible for the inhibition 
of function is the blockade of NR1 synthesis induced by suppression of N-glycosylation. Contrary to that, 
synthesis of NR2A, likewise a N-glycosylated subunit, is not affected by the inhibition of N-glycosylation, 
although ngNR2A cannot be transported to the cell membrane and forms intracellular aggregates.   
A similar response of NR1 subunits to ER dysfunction can be also observed in cortical neurons briefly 
treated with tunicamycin (7 h). Subunit NR1 has a differential sensitivity to inhibition of N-glycosylation 
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compared to NR2A and NR2B, and newly synthesized NR1 mostly disappears before exit of the ER. In 
addition to that, the limited ngNR1 protein expressed in neurons treated with tunicamycin is not able to 
establish interactions with ngNR2 subunits and, therefore, to form heteromeric NMDARs. These results, 
together with the observation that levels of NR1 mRNA are not affected by short tunicamycin treatment, 
strongly suggest that misfolding of proteins due to inhibition of N-glycosylation might induce specific ER 
stress responses and differential degradation of ngNR1 but not the ngNR2 proteins. In fact, activation of ER 
stress responses of the UPR type could be demonstrated in neurons treated with tunicamycin and, in such 
cellular context, degradation of ngNR1 takes place with the participation of the ubiquitin/proteasome system 
showing ngNR1 as a specific substrate for the ERAD response. However, given that proteasomal inhibition 
does not completely prevents ngNR1 degradation, we cannot exclude the participation of other mechanisms 
in NR1 regulation by ER stress, such as a specific blockage of mRNA translation or the disposal of defective 
subunits by proteolytic systems different to the proteasome (Frigerio and Lord 2000). It will be interesting to 
investigate if these alternative mechanisms are really involved in NR1 regulation. 
The data presented here and our previous results (Garcia-Gallo et al. 2001) clearly establish NR1 as a 
protein highly dependent on N-glycosylation for stability and assembly. Since transport of newly 
synthesized NR2 subunits to the cell membrane requires synthesis of NR1 as demonstrated in a NR1 
knockout mice (Fukaya et al. 2003), it is very probable that inhibition of NR1 synthesis by tunicamycin will 
cause the intracellular retention of newly synthesized NR2 subunits similarly to the heterologous system. 
Being NR1 an obligatory NMDAR component, the result will be a progressive decrease in the levels of 
synaptic and extra-synaptic NMDARs.  Nonetheless, the molecular mechanisms responsible for the 
differential sensitivity of NR1 and NR2A/B subunits to ER stress are still unknown. The events leading to 
the sorting and targeting of specific substrates to the translocation pore for their degradation are not clear.  
What is the relevance of our results to brain physiology? Several data in the literature point to the 
induction of ER stress in neurons in some physiological and pathological situations of the central nervous 
system (Paschen and Mengesdorf 2005). Additionally, congenital defects in the biosynthesis of N-linked 
Page 16 of 63
Journal of Neuroscience Research
Journal of Neuroscience Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
17
glycans cause severe multisystemic disorders with frequently impaired central nervous function (Jaeken 
2003; Freeze 2006). In these situations, the earliest events in the biogenesis of critical molecules in 
functioning of the central nervous system, such as the NMDAR, might be inhibited. Since the synaptic 
NMDARs are fundamental for neuronal survival in the adult brain (Hardingham et al. 2002; Papadia et al. 
2005), a decrease in receptor function due to NR1 degradation as a consequence of ER stress might be 
contributing to neuronal injury. 
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Figure legends 
Figure 1. Inhibition of calcium influx mediated by a recombinant NMDAR after blockage of N-
glycosylation. HEK293 cells (0.8 x 106) were infected with 4 pfu/cell of recombinant virus vTF7-3 and 
transfected with NR1 and NR2A genes (4 µg of each plasmid) or NR1 alone as a control (8 µg). After 24 h 
in the presence of 2 mM DL-AP5, with or without 2 µg/ml tunicamycin (Tn) as indicated, cells were washed 
and incubated with 45CaCl2 together with 2 mM NMDA and 10µM glycine, in the presence or absence of 
MK-801 (10 µM) and tunicamycin for 5 min.  Mean values of the net accumulation of 45Ca2+ during this 
time, corresponding to three independent experiments with standard deviations are given. To assess the 
differences between cells subjected to different treatments, statistic analysis was done with one-way 
ANOVA plus a Tukey`s post test (***p <0.001). 
Figure 2. Blockade on synthesis of the NR1 but not the NR2A subunits expressed in heterologous 
systems after inhibition of the N-glycosylation. A. Pulse-labeling of NMDAR subunits. HEK293 cells were 
infected as before and transfected with NR1 and NR2A genes (4 µg of each plasmid) or control DNA (C) (8 
µg). Infection proceeded for 24 h in the presence of 2 mM DL-AP5 and, then, cells were incubated for 3 h in 
DMEM lacking methionine, with or without 2 µg/ml of tunicamycin (Tn) as indicated. Then, they were 
pulsed for 30 min with 150 µCi/ml of 35S-methionine in the same medium used for starvation. The effect of 
N-glycosylation inhibition on the synthesis de novo of NMDAR subunits was analyzed by 
immunoprecipitation (IP) of cell extracts with antibodies specific for NR1 (IPNR1, upper panel) or 
conserved regions in the C-termini of NR2A and NR2B subunits (IPNR2, lower panel), electrophoretic 
fractionation and autoradiographic detection. The expected mobilities of glycosylated and nonglycosylated 
(ng) subunits are indicated on the right. Results are representative of four independent experiments. B. 
Effect of short tunicamycin treatment on the steady-state levels of NMDAR subunits. Proteins 
immunoprecipitated as described were analysed by immunoblotting (IB) using NR1 (IBNR1) and NR2 
(IBNR2) antibodies as above. C. Recognition of in vitro deglycosylated NR1 by specific antibodies. 
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Protein extracts (30 µg) corresponding to cells infected/transfected as before without tunicamycin were 
treated with N-glycosidase F (NGlyF) as indicated by the manufacturers or left untreated. Then, 
immunoprecipitation of NR1 (upper panel) and NR2A (lower panel) was performed as described, and 
proteins were detected by immunoblotting. The presented results are representative of three independent 
experiments. D. Effect of the tunicamycin treatment on levels and location of the NMDAR subunits. 
HEK293 cells were transfected with YFP-NR1 and pME18S-HA-NR2A (0.5 µg of each plasmid) as 
indicated. After 5 h of transfection, incubation proceeded for additional 24 h with 2 mM DL-AP5, with or 
without 2 µg/ml of tunicamycin as specified. Double immunofluorescence of permeabilized cells was 
performed to study levels of the NR1 subunit (green) and NR2A (red). Confocal microscopy images 
correspond to a single section. Arrows denote regions of subunit co-expression in the plasma membrane of 
untreated cells. Arrowheads point to aggregates of NR2A found in tunicamycin-treated cells. Results are 
representative of three independent experiments. The scale bars represent 5 µm. 
Figure 3. Blockade on de novo synthesis of NR1 but not NR2 subunits induced by the inhibition of the 
N-glycosylation in primary cultures of cortical neurons. A. Primary cultures of rat cortical neurons (DIVs 
14) were labeled for 4 h with 35S-methionine (150 µCi/ml) in the presence or absence of tunicamycin (2 
µg/ml) as indicated, also present 3 h before labeling during methionine starvation. Cell extracts prepared 
using RIPA buffer containing 0.5% SDS were immunoprecipitated with antibodies specific for the NR1 
subunit or NR2, and proteins detected by autoradiography. B. Quantitation of newly synthesized NR1 and 
NR2. Levels of 35S-labeled subunits were established by densitometric analysis of autoradiographies using 
NIH Image software. Values obtained in cells treated with tunicamycin were referred to those found in 
untreated cells, arbitrarily given a 100 percent value. Average of three independent experiments with 
standard deviations is given. To assess the differences, statistic analysis was done with one-way ANOVA 
plus a Tukey`s post test using Prism v4 software (***p <0.001). Immunoprecipitated proteins as before were 
analyzed by immunoblot with antibodies specific for the NR2 (C) or NR1 (D) subunits. 
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Figure 4. Disruption of NMDAR assembly induced by inhibition of the N-glycosylation in cortical 
neurons. Cultures of cortical neurons were labeled with 35S-methionine as before in the presence of 
tunicamycin (2 µg/ml) and/or brefeldin A (Bf) (5 µg/ml) as indicated. Cell extracts prepared using standard 
RIPA buffer (0.1% SDS) were immunoprecipitated using antibodies against the NR1 (A) or NR2 subunits 
(B). Directly immunoprecipitated and interacting proteins were detected by autoradiography. Results are 
representative of three independent experiments. 
Figure 5. Induction of ER stress responses by inhibition of N-glycosylation in cultured cortical 
neurons. A. Primary cultures of cortical neurons (DIVs 14) were incubated with tunicamycin (2 µg/ml) as 
before for 7 or 24 h or, alternatively, left untreated. Total RNA obtained from these cells was analyzed by 
Northern blot using 32P-labeled DNA probes specific for NR1, calnexin, BiP/grp78 or CHOP/GADD153 
mRNAs. Ethidium bromide staining of total RNA is also shown. B. Total protein lysates were prepared from 
cortical neurons treated with tunicamycin as before and analyzed by immunoblot with antibodies specific for 
CHOP/GADD153, caspase-12 or calnexin. The presented results are representative of three independent 
experiments. 
Figure 6. Blockade of the synthesis of NR1 induced by inhibition of the N-glycosylation of cortical 
neurons is partially due to proteasomal degradation. A. Cultures of rat cortical neurons (DIVs 14) were 
labeled as before in the presence of tunicamycin (2 µg/ml) and/or the proteasome inhibitor MG132 (50 µM). 
Cell extracts were immunoprecipitated using antibodies for NR1 (upper panel) or calnexin (lower panel). 
Immunoprecipitated proteins were detected by autoradiography. B. Quantitation of newly synthesized NR1 
in cells treated with tunicamycin and MG132. Levels of 35S-labeled subunits were established by 
densitometric analysis of autoradiographies using NIH Image software. Values obtained were referred to 
those found in the untreated cells, arbitrarily given a 100 percent value. Average of three independent 
experiments with standard deviations is given. To assess the differences between cells subjected to different 
treatments, statistic analysis was done with one-way ANOVA plus a Tukey`s post test using Prism v4 
software (***p <0.001). C. Proteins immunoprecipitated with the NR1 antibody as above were analyzed by 
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immunoblot with ubiquitin specific sera. These results are representative of three independent experiments. 
D. Cortical neurons were labeled as described in the presence of tunicamycin (2 µg/ml) and/or the 
proteasome inhibitors ALLN (50 µM) and lactacystin (Lact; 50 µM), as well as control peptide ALLM (50 
µM) as indicated. Cell extracts were prepared and analyzed as before.  
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